These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 37908982

  • 1. Successful Management of Cushing Syndrome From Ectopic ACTH Secretion in an Adolescent With Osilodrostat.
    Blew K, Van Mater D, Page L.
    JCEM Case Rep; 2023 Jul; 1(4):luad101. PubMed ID: 37908982
    [Abstract] [Full Text] [Related]

  • 2. A Case of an Ectopic ACTH-Producing Tumor With Adrenal Shrinkage During Osilodrostat Administration.
    Sawabe F, Hayafusa R, Kosugi R, Ariyasu H.
    JCEM Case Rep; 2024 Feb; 2(2):luae008. PubMed ID: 38283731
    [Abstract] [Full Text] [Related]

  • 3. Unusual cause of ectopic secretion of adrenocorticotropic hormone: Cushing syndrome attributable to small cell prostate cancer.
    Alshaikh OM, Al-Mahfouz AA, Al-Hindi H, Mahfouz AB, Alzahrani AS.
    Endocr Pract; 2010 Feb; 16(2):249-54. PubMed ID: 20061271
    [Abstract] [Full Text] [Related]

  • 4. Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study.
    Creemers SG, Feelders RA, de Jong FH, Franssen GJH, de Rijke YB, van Koetsveld PM, Hofland LJ.
    J Clin Endocrinol Metab; 2019 Aug 01; 104(8):3437-3449. PubMed ID: 31127821
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France.
    Dormoy A, Haissaguerre M, Vitellius G, Do Cao C, Geslot A, Drui D, Lasolle H, Vieira-Pinto O, Salenave S, François M, Puerto M, Boullay HD, Mayer A, Rod A, Laurent C, Chanson P, Reznik Y, Castinetti F, Chabre O, Baudin E, Raverot G, Tabarin A, Young J.
    J Clin Endocrinol Metab; 2023 May 17; 108(6):1475-1487. PubMed ID: 36470583
    [Abstract] [Full Text] [Related]

  • 6. Ectopic ACTH-secreting pituitary adenoma of the sphenoid sinus: case report of endoscopic endonasal resection and systematic review of the literature.
    Seltzer J, Lucas J, Commins D, Lerner O, Lerner A, Carmichael JD, Zada G.
    Neurosurg Focus; 2015 Feb 17; 38(2):E10. PubMed ID: 25639312
    [Abstract] [Full Text] [Related]

  • 7. Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome.
    Landry JP, Clemente-Gutierrez U, Pieterman CRC, Chiang YJ, Waguespack SG, Jimenez C, Habra MA, Halperin DM, Fisher SB, Graham PH, Perrier ND.
    Surgery; 2022 Aug 17; 172(2):559-566. PubMed ID: 35437162
    [Abstract] [Full Text] [Related]

  • 8. Recurrent acute-onset Cushing's syndrome 6 years after removal of a thymic neuroendocrine carcinoma: from ectopic ACTH to CRH.
    Schalin-Jäntti C, Asa SL, Arola J, Sane T.
    Endocr Pathol; 2013 Mar 17; 24(1):25-9. PubMed ID: 23233312
    [Abstract] [Full Text] [Related]

  • 9. ECTOPIC CUSHING SYNDROME: A 10-YEAR EXPERIENCE FROM A TERTIARY CARE CENTER IN SOUTHERN INDIA.
    Sathyakumar S, Paul TV, Asha HS, Gnanamuthu BR, Paul MJ, Abraham DT, Rajaratnam S, Thomas N.
    Endocr Pract; 2017 Aug 17; 23(8):907-914. PubMed ID: 28614007
    [Abstract] [Full Text] [Related]

  • 10. Adrenal Cushing's Syndrome Treated With Preoperative Osilodrostat and Adrenalectomy.
    Malik RB, Ben-Shlomo A.
    AACE Clin Case Rep; 2022 Aug 17; 8(6):267-270. PubMed ID: 36447826
    [Abstract] [Full Text] [Related]

  • 11. Severe ectopic Cushing syndrome in a transgender man with a metastatic gastrinoma and an adrenal tumor-A case report and review of the literature.
    Wydra A, Cylke-Falkowska K, Czajka-Oraniec I, Kolasińska-Ćwikła A, Ćwikła J, Zgliczyński W, Stelmachowska-Banaś M.
    Front Endocrinol (Lausanne); 2023 Aug 17; 14():1135016. PubMed ID: 37008936
    [Abstract] [Full Text] [Related]

  • 12. Osilodrostat: A Review of Recent Clinical Studies and Practical Recommendations for its Use in the Treatment of Cushing Disease.
    Yuen KCJ.
    Endocr Pract; 2021 Sep 17; 27(9):956-965. PubMed ID: 34389514
    [Abstract] [Full Text] [Related]

  • 13. Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients.
    Bonnet-Serrano F, Poirier J, Vaczlavik A, Laguillier-Morizot C, Blanchet B, Baron S, Guignat L, Bessiene L, Bricaire L, Groussin L, Assié G, Guibourdenche J, Bertherat J.
    Eur J Endocrinol; 2022 Aug 01; 187(2):315-322. PubMed ID: 35699971
    [Abstract] [Full Text] [Related]

  • 14. Persistent hypokalemia after successful adrenalectomy in a patient with Cushing's syndrome due to ectopic ACTH secretion: possible role of 11beta-hydroxysteroid dehydrogenase inhibition.
    Arteaga E, Fardella C, Campusano C, Cárdenas I, Martinez P.
    J Endocrinol Invest; 1999 Dec 01; 22(11):857-9. PubMed ID: 10710274
    [Abstract] [Full Text] [Related]

  • 15. Fluconazole treatment in severe ectopic Cushing syndrome.
    Canteros TM, De Miguel V, Fainstein-Day P.
    Endocrinol Diabetes Metab Case Rep; 2019 Jul 09; 2019(1):. PubMed ID: 31373475
    [Abstract] [Full Text] [Related]

  • 16. The first description of metyrapone use in severe Cushing Syndrome due to ectopic ACTH secretion in an infant with immature sacrococcygeal teratoma. Case Report.
    Wojcik M, Kalicka-Kasperczyk A, Luszawska-Kutrzeba T, Balwierz W, Starzyk JB.
    Neuro Endocrinol Lett; 2015 Dec 09; 36(7):653-5. PubMed ID: 26859587
    [Abstract] [Full Text] [Related]

  • 17. [The ectopic ACTH syndrome].
    Penezić Z, Savić S, Vujović S, Tatić S, Ercegovac M, Drezgićc M.
    Srp Arh Celok Lek; 2004 Dec 09; 132(1-2):28-32. PubMed ID: 15227962
    [Abstract] [Full Text] [Related]

  • 18. Clinical Utility of Osilodrostat in Cushing's Disease: Review of Currently Available Literature.
    Perosevic M, Tritos NA.
    Drug Des Devel Ther; 2023 Dec 09; 17():1303-1312. PubMed ID: 37143705
    [Abstract] [Full Text] [Related]

  • 19. Bilateral adrenalectomy: lifesaving procedure in severe Cushing syndrome.
    Han JY, Mirsadraei L, Yeh MW, Suh JD, Yong WH, Bergsneider M, Heaney AP.
    Endocr Pract; 2012 Dec 09; 18(4):e85-90. PubMed ID: 22441001
    [Abstract] [Full Text] [Related]

  • 20. Medullary thyroid carcinoma with ectopic adrenocorticotropic hormone syndrome.
    Choi HS, Kim MJ, Moon CH, Yoon JH, Ku HR, Kang GW, Na II, Lee SS, Lee BC, Park YJ, Kim HI, Ku YH.
    Endocrinol Metab (Seoul); 2014 Mar 09; 29(1):96-100. PubMed ID: 24741461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.